Accumulated evidences have showed that Cyclin B1 were overexpressed in breast cancer, esophageal squamous cell carcinoma, lung cancer, gastric cancer, hepatocellular cancer, and other cancer cells [31, 32, 41–43]. This evidence concerns the gene CCNB1 and breast carcinoma.